Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiomyopathy, Hypertrophic | 12 | 2021 | 116 | 2.460 |
Why?
|
| Catheter Ablation | 7 | 2021 | 229 | 1.360 |
Why?
|
| Ablation Techniques | 3 | 2021 | 33 | 1.210 |
Why?
|
| Ethanol | 10 | 2021 | 893 | 0.960 |
Why?
|
| Heart Septum | 8 | 2021 | 84 | 0.860 |
Why?
|
| Cardiac Catheterization | 6 | 2020 | 419 | 0.640 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2021 | 450 | 0.580 |
Why?
|
| Pulmonary Wedge Pressure | 3 | 2020 | 102 | 0.370 |
Why?
|
| Hypertension, Pulmonary | 2 | 2020 | 232 | 0.290 |
Why?
|
| Treatment Outcome | 12 | 2021 | 7029 | 0.270 |
Why?
|
| Heart Failure | 4 | 2019 | 1180 | 0.270 |
Why?
|
| Middle Aged | 19 | 2021 | 21147 | 0.230 |
Why?
|
| Coronary Angiography | 6 | 2013 | 866 | 0.230 |
Why?
|
| Ventricular Function, Left | 5 | 2018 | 481 | 0.230 |
Why?
|
| Aged | 13 | 2021 | 14862 | 0.220 |
Why?
|
| Atrial Pressure | 2 | 2018 | 9 | 0.190 |
Why?
|
| Stroke Volume | 3 | 2019 | 586 | 0.190 |
Why?
|
| Coronary Vessels | 2 | 2013 | 313 | 0.180 |
Why?
|
| Prospective Studies | 9 | 2020 | 3705 | 0.180 |
Why?
|
| Vascular Endothelial Growth Factor D | 1 | 2019 | 10 | 0.170 |
Why?
|
| Female | 17 | 2021 | 38074 | 0.160 |
Why?
|
| Pulmonary Artery | 1 | 2020 | 323 | 0.150 |
Why?
|
| Heart-Assist Devices | 2 | 2018 | 221 | 0.150 |
Why?
|
| Atrial Function, Left | 1 | 2017 | 10 | 0.150 |
Why?
|
| Cardiac Catheters | 1 | 2017 | 12 | 0.150 |
Why?
|
| Humans | 23 | 2021 | 68618 | 0.150 |
Why?
|
| Heart Atria | 1 | 2018 | 206 | 0.150 |
Why?
|
| Echocardiography, Doppler | 4 | 2010 | 87 | 0.150 |
Why?
|
| Adult | 9 | 2021 | 21403 | 0.150 |
Why?
|
| Defibrillators, Implantable | 2 | 2010 | 329 | 0.130 |
Why?
|
| Time Factors | 4 | 2017 | 4655 | 0.120 |
Why?
|
| Male | 16 | 2020 | 37321 | 0.120 |
Why?
|
| Recovery of Function | 2 | 2017 | 506 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2008 | 2324 | 0.110 |
Why?
|
| Blood Flow Velocity | 1 | 2013 | 172 | 0.110 |
Why?
|
| Coronary Circulation | 1 | 2013 | 136 | 0.110 |
Why?
|
| Angioplasty, Balloon, Coronary | 2 | 2012 | 178 | 0.110 |
Why?
|
| Coronary Artery Disease | 2 | 2013 | 696 | 0.100 |
Why?
|
| Follow-Up Studies | 5 | 2008 | 3259 | 0.100 |
Why?
|
| Coronary Aneurysm | 2 | 2008 | 19 | 0.100 |
Why?
|
| Radial Artery | 1 | 2012 | 43 | 0.100 |
Why?
|
| Lipids | 1 | 2013 | 298 | 0.100 |
Why?
|
| Hospital Mortality | 1 | 2013 | 384 | 0.090 |
Why?
|
| Differential Threshold | 1 | 2010 | 27 | 0.090 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2010 | 14 | 0.090 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2010 | 36 | 0.090 |
Why?
|
| Patient Safety | 1 | 2012 | 202 | 0.090 |
Why?
|
| Electric Countershock | 1 | 2010 | 130 | 0.090 |
Why?
|
| Coronary Stenosis | 2 | 2013 | 246 | 0.080 |
Why?
|
| Patient Selection | 1 | 2013 | 592 | 0.080 |
Why?
|
| Retrospective Studies | 4 | 2021 | 7277 | 0.080 |
Why?
|
| Comorbidity | 1 | 2013 | 1426 | 0.080 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2008 | 20 | 0.080 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 277 | 0.080 |
Why?
|
| Age Factors | 1 | 2013 | 1864 | 0.080 |
Why?
|
| Injections, Intra-Arterial | 2 | 2008 | 30 | 0.080 |
Why?
|
| Heart Block | 2 | 2008 | 49 | 0.080 |
Why?
|
| Catheterization | 1 | 2008 | 209 | 0.070 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2008 | 141 | 0.070 |
Why?
|
| Blood Pressure | 1 | 2013 | 1451 | 0.070 |
Why?
|
| Risk Assessment | 3 | 2021 | 2007 | 0.070 |
Why?
|
| Risk Factors | 2 | 2013 | 5731 | 0.070 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 2 | 2020 | 61 | 0.070 |
Why?
|
| Coronary Disease | 1 | 2007 | 358 | 0.060 |
Why?
|
| Anxiety | 1 | 2007 | 422 | 0.060 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2007 | 373 | 0.060 |
Why?
|
| Sensitivity and Specificity | 3 | 2019 | 1753 | 0.060 |
Why?
|
| Exercise Tolerance | 2 | 2017 | 75 | 0.060 |
Why?
|
| Angioplasty, Balloon | 1 | 2003 | 110 | 0.050 |
Why?
|
| Diastole | 1 | 2003 | 161 | 0.050 |
Why?
|
| Exercise Test | 1 | 2003 | 242 | 0.050 |
Why?
|
| Injections | 1 | 2002 | 119 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2013 | 4848 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 1465 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2003 | 453 | 0.050 |
Why?
|
| Angina Pectoris | 2 | 2013 | 61 | 0.050 |
Why?
|
| Renal Dialysis | 1 | 2001 | 174 | 0.050 |
Why?
|
| Cardiac Conduction System Disease | 1 | 2020 | 11 | 0.050 |
Why?
|
| Bundle-Branch Block | 1 | 2021 | 50 | 0.050 |
Why?
|
| Depression | 1 | 2007 | 943 | 0.050 |
Why?
|
| Lymphangiogenesis | 1 | 2019 | 10 | 0.040 |
Why?
|
| Quality of Life | 1 | 2007 | 1515 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 1851 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2019 | 169 | 0.040 |
Why?
|
| Prosthesis Implantation | 1 | 2018 | 83 | 0.040 |
Why?
|
| Europe | 1 | 2017 | 196 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2008 | 536 | 0.040 |
Why?
|
| South Carolina | 3 | 2012 | 2752 | 0.040 |
Why?
|
| Australia | 1 | 2017 | 235 | 0.040 |
Why?
|
| Electrocardiography | 2 | 2010 | 601 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2017 | 301 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2019 | 705 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 1038 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 2077 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2003 | 1615 | 0.030 |
Why?
|
| Adolescent | 2 | 2008 | 8912 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2018 | 1738 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2019 | 1330 | 0.030 |
Why?
|
| Prognosis | 1 | 2019 | 2093 | 0.030 |
Why?
|
| Biomarkers | 1 | 2019 | 1593 | 0.030 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2013 | 31 | 0.030 |
Why?
|
| Adenosine | 1 | 2013 | 165 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2013 | 219 | 0.030 |
Why?
|
| Hirudins | 1 | 2012 | 32 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 2013 | 172 | 0.020 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2012 | 80 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 2012 | 65 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2012 | 119 | 0.020 |
Why?
|
| Radionuclide Ventriculography | 1 | 2010 | 6 | 0.020 |
Why?
|
| Heparin | 1 | 2012 | 205 | 0.020 |
Why?
|
| Fellowships and Scholarships | 1 | 2012 | 127 | 0.020 |
Why?
|
| Fluoroscopy | 1 | 2012 | 152 | 0.020 |
Why?
|
| Cardiology | 1 | 2012 | 140 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 742 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2013 | 867 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2012 | 373 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2012 | 483 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2012 | 356 | 0.020 |
Why?
|
| Injections, Intralesional | 1 | 2008 | 25 | 0.020 |
Why?
|
| Acute Coronary Syndrome | 1 | 2010 | 195 | 0.020 |
Why?
|
| Texas | 1 | 2008 | 92 | 0.020 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2008 | 33 | 0.020 |
Why?
|
| Length of Stay | 1 | 2012 | 780 | 0.020 |
Why?
|
| Probability | 1 | 2008 | 245 | 0.020 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2008 | 99 | 0.020 |
Why?
|
| Dyspnea | 1 | 2008 | 87 | 0.020 |
Why?
|
| Primary Prevention | 1 | 2008 | 115 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 807 | 0.020 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2008 | 174 | 0.020 |
Why?
|
| Coronary Artery Bypass | 1 | 2008 | 218 | 0.020 |
Why?
|
| Solvents | 1 | 2007 | 109 | 0.020 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2008 | 164 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2012 | 657 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 951 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 546 | 0.020 |
Why?
|
| Survival Rate | 1 | 2008 | 1056 | 0.020 |
Why?
|
| United States | 1 | 2017 | 7367 | 0.020 |
Why?
|
| Mental Health | 1 | 2007 | 278 | 0.020 |
Why?
|
| Contrast Media | 1 | 2007 | 595 | 0.010 |
Why?
|
| Time | 1 | 2001 | 57 | 0.010 |
Why?
|
| Algorithms | 1 | 2007 | 1196 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 2007 | 824 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2001 | 714 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2007 | 2800 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2001 | 365 | 0.010 |
Why?
|
| Stents | 1 | 2001 | 657 | 0.010 |
Why?
|